CurrentEndo
Get Weekly

Topic · page 75 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,961–3,000 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Risks of peri‐ and postoperative complications with glucagon‐like peptide‐1 receptor agonists

    Cohort study

  2. Diabetes Obes Metab

    Metformin use associated with lower rate of hospitalization for influenza in individuals with diabetes

    Cohort study

  3. J Clin Endocrinol Metab

    Titration of Sedentary Behavior With Varying Physical Activity Levels Reduces Mortality in Patients With Type 2 Diabetes

    Cohort study

  4. Cardiovasc Diabetol

    The association between the triglyceride–glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study

    Cross-sectional study

  5. Diabetes Obes Metab

    Cost‐utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide

    Research article

  6. J Bone Miner Res

    Effect of abdominal tissue thickness on trabecular bone score and fracture risk in adults with diabetes: the Manitoba BMD registry

    Cohort study

  7. J Clin Endocrinol Metab

    Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test

    Cross-sectional study

  8. Obesity (Silver Spring)

    Long‐term sustained effects of the Look AHEAD lifestyle intervention on body composition among adults with type 2 diabetes

    Secondary analysis

  9. Diabetes Care

    Polygenic Risk Score Modifies the Association of HbA1c With Hearing Loss in Middle-Aged and Older Chinese Individuals: The Dongfeng-Tongji Cohort

    Cross-sectional study

  10. Cardiovasc Diabetol

    Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment

    Randomized controlled trial

  11. Cardiovasc Diabetol

    Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies

    Cohort study

  12. Diabetes Res Clin Pract

    Accessing the relationship between six surrogate insulin resistance indexes and the incidence of rapid kidney function decline and the progression to chronic kidney disease among middle-aged and older adults in China: Results from the China health and retirement longitudinal study

    Cohort study

  13. Diabet Med

    Ethnic disparities in quality of diabetes care in Scotland: A national cohort study

    Cohort study

  14. BMJ

    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data

    Cohort study

  15. Endocr Pract

    Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment

    Cohort study

  16. Diabetes Obes Metab

    Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes

    Cross-sectional study

  17. Diabetes Obes Metab

    A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes ( AWARD‐JPN )

    Randomized controlled trial

  18. Diabetes Res Clin Pract

    Prediabetes, participation in the English National Health Service Diabetes Prevention Programme, and associations with COVID-19-related mortality: A whole population study

    Cohort study

  19. Cardiovasc Diabetol

    Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

    Research article

  20. Cardiovasc Diabetol

    SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study

    Research article

  21. Diabetes Res Clin Pract

    National trends in utilisation of glucose lowering medicines by older people with diabetes in long-term care facilities

    Cross-sectional study

  22. BMJ Open Diabetes Res Care

    Eight-year nationwide study of the bidirectional association between type 2 diabetes and depression in nearly 8 million German outpatients

    Cohort study

  23. J Clin Endocrinol Metab

    Association Between Visceral Obesity Index and Diabetes: A Systematic Review and Meta-analysis

    Meta-analysis

  24. Diabetes Care

    Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020

    Cohort study

  25. Diabetes Res Clin Pract

    Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021

    Research article

  26. Diabetes Obes Metab

    Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction‐associated steatotic liver disease: A retrospective nationwide claims database study in Japan

    Cohort study

  27. BMJ Open Diabetes Res Care

    Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis

    Cohort study

  28. BMJ Open Diabetes Res Care

    Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study

    Research article

  29. J Clin Endocrinol Metab

    N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome

    Cohort study

  30. Diabetes Metab

    Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes

    Cross-sectional study

  31. Lancet Diabetes Endocrinol

    Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies

    Cohort study

  32. Cardiovasc Diabetol

    Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study

    Diagnostic or prognostic study

  33. Diabetes Obes Metab

    Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter ‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial

    Randomized controlled trial

  34. J Clin Endocrinol Metab

    Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants

    Cohort study

  35. J Clin Endocrinol Metab

    Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis

    Secondary analysis

  36. Diabetes Obes Metab

    Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020

    Cross-sectional study

  37. Diabetes Obes Metab

    Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population‐based cohort study

    Cohort study

  38. Diabetes Obes Metab

    Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia

    Cross-sectional study

  39. Diabetes Res Clin Pract

    Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists

    Cohort study

  40. Lancet Diabetes Endocrinol

    Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 2,961–3,000 of 4,758, newest first